The company has successfully scaled operating income to $362.6 million in 2026Q1, maintaining gross margins above 60% throughout the last ten quarters.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Sales/Revenue | 4.45B | 4.3B | 3.9B | 3.66B | 3.37B | 3.22B | 2.71B | 2.41B | 2.21B | 1.97B | 1.78B | 1.6B | 1.49B | 1.38B | 1.29B | 1.22B | 1.1B | 1.03B | 1.02B | 922.55M | 739.12M | 638.1M | 549.18M | 475.99M | 412.67M | 386.08M | 367.43M | 356.2M | 319.9M | 263M | 267.7M |
| Revenue Growth % | 13.08% | 10.42% | 6.46% | 8.72% | 4.73% | 18.79% | 12.45% | 8.75% | 12.4% | 10.91% | 10.83% | 7.81% | 7.9% | 6.47% | 6.13% | 10.45% | 6.96% | 0.74% | 11% | 24.82% | 15.83% | 16.19% | 15.38% | 15.34% | 6.89% | 5.08% | 3.15% | 11.35% | 21.63% | -1.76% | 41.94% |
| Cost of Goods Sold | 1.69B | 1.64B | 1.52B | 1.47B | 1.36B | 1.33B | 1.14B | 1.04B | 971.7M | 871.68M | 799.99M | 711.62M | 669.69M | 620.94M | 594.19M | 572.18M | 524.77M | 505.35M | 494.26M | 459.03M | 359.59M | 315.19M | 270.16M | 245.69M | 219.94M | 202.75M | 170.78M | 164.9M | 142.2M | 119.8M | 102.9M |
| COGS % of Revenue | - | 38.2% | 38.96% | 40.18% | 40.48% | 41.24% | 41.96% | 43.27% | 43.9% | 44.27% | 45.06% | 44.42% | 45.07% | 45.09% | 45.94% | 46.95% | 47.56% | 48.99% | 48.27% | 49.76% | 48.65% | 49.4% | 49.19% | 51.62% | 53.3% | 52.51% | 46.48% | 46.29% | 44.45% | 45.55% | 38.44% |
| Gross Profit | 2.76B | 2.66B | 2.38B | 2.19B | 2B | 1.89B | 1.57B | 1.37B | 1.24B | 1.1B | 975.44M | 890.27M | 816.12M | 756.12M | 699.15M | 646.51M | 578.62M | 526.28M | 529.77M | 463.52M | 379.53M | 322.9M | 279.02M | 230.3M | 192.72M | 183.33M | 196.66M | 191.3M | 177.7M | 143.2M | 164.8M |
| Gross Margin % | 62.05% | 61.8% | 61.04% | 59.82% | 59.52% | 58.76% | 58.04% | 56.73% | 56.1% | 55.73% | 54.94% | 55.58% | 54.93% | 54.91% | 54.06% | 53.05% | 52.44% | 51.01% | 51.73% | 50.24% | 51.35% | 50.6% | 50.81% | 48.38% | 46.7% | 47.49% | 53.52% | 53.71% | 55.55% | 54.45% | 61.56% |
| Gross Profit Growth % | - | 11.8% | 8.63% | 9.26% | 6.08% | 20.27% | 15.05% | 9.99% | 13.14% | 12.5% | 9.57% | 9.09% | 7.94% | 8.15% | 8.14% | 11.73% | 9.95% | -0.66% | 14.29% | 22.13% | 17.54% | 15.73% | 21.15% | 19.5% | 5.12% | -6.78% | 2.8% | 7.65% | 24.09% | -13.11% | 45.33% |
| Operating Expenses | 1.35B | 1.3B | 1.25B | 1.09B | 1.11B | 957.4M | 876.52M | 812.7M | 750.21M | 684.35M | 625.2M | 582.15M | 555.86M | 489.36M | 436.58M | 410.28M | 374.74M | 350.31M | 357.31M | 327.34M | 251.6M | 207.57M | 170.98M | 149.92M | 126.91M | 126.78M | 143.41M | 144.5M | 148.6M | 147.6M | 117.8M |
| OpEx % of Revenue | - | 30.2% | 32.09% | 29.85% | 32.83% | 29.78% | 32.38% | 33.77% | 33.9% | 34.76% | 35.21% | 36.34% | 37.41% | 35.54% | 33.76% | 33.67% | 33.96% | 33.96% | 34.89% | 35.48% | 34.04% | 32.53% | 31.13% | 31.5% | 30.75% | 32.84% | 39.03% | 40.57% | 46.45% | 56.12% | 44% |
| Selling, General & Admin | 1.09B | 1.05B | 1.03B | 901.89M | 850.75M | 796.39M | 735.27M | 679.51M | 632.34M | 575.17M | 524.08M | 482.46M | 457.6M | 401.35M | 354.57M | 334.24M | 306.14M | 285.19M | 285.28M | 260M | 197.98M | 166.62M | 135.58M | 117.6M | 97.58M | 98.35M | 95.63M | 100M | 111.2M | 116.1M | 95.2M |
| SG&A % of Revenue | - | 24.36% | 26.45% | 24.64% | 25.26% | 24.77% | 27.17% | 28.23% | 28.57% | 29.21% | 29.52% | 30.12% | 30.8% | 29.15% | 27.42% | 27.43% | 27.75% | 27.64% | 27.86% | 28.18% | 26.79% | 26.11% | 24.69% | 24.71% | 23.65% | 25.47% | 26.03% | 28.07% | 34.76% | 44.14% | 35.56% |
| Research & Development | 257.93M | 251.21M | 219.79M | 190.95M | 254.82M | 161.01M | 141.25M | 133.19M | 117.86M | 109.18M | 101.12M | 99.68M | 98.26M | 88M | 82.01M | 76.04M | 68.6M | 65.12M | 70.55M | 67.34M | 53.62M | 40.95M | 35.4M | 32.32M | 29.33M | 28.43M | 28.29M | 27.3M | 21.5M | 17.1M | 12.2M |
| R&D % of Revenue | - | 5.84% | 5.64% | 5.22% | 7.57% | 5.01% | 5.22% | 5.53% | 5.33% | 5.54% | 5.7% | 6.22% | 6.61% | 6.39% | 6.34% | 6.24% | 6.22% | 6.31% | 6.89% | 7.3% | 7.25% | 6.42% | 6.45% | 6.79% | 7.11% | 7.36% | 7.7% | 7.66% | 6.72% | 6.5% | 4.56% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 2.2M | 1.46M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 1.41B | 1.36B | 1.13B | 1.1B | 898.76M | 932.03M | 694.52M | 552.85M | 491.33M | 413.03M | 350.24M | 299.91M | 260.25M | 266.76M | 262.56M | 236.22M | 203.88M | 175.97M | 172.46M | 136.18M | 127.93M | 115.33M | 108.03M | 80.39M | 65.81M | 56.55M | 53.25M | 46.8M | 29.1M | -4.4M | 47M |
| Operating Margin % | 31.63% | 31.6% | 28.95% | 29.97% | 26.69% | 28.99% | 25.66% | 22.97% | 22.2% | 20.98% | 19.73% | 18.72% | 17.52% | 19.37% | 20.3% | 19.38% | 18.48% | 17.06% | 16.84% | 14.76% | 17.31% | 18.07% | 19.67% | 16.89% | 15.95% | 14.65% | 14.49% | 13.14% | 9.1% | -1.67% | 17.56% |
| Operating Income Growth % | - | 20.53% | 2.84% | 22.07% | -3.57% | 34.2% | 25.63% | 12.52% | 18.96% | 17.93% | 16.78% | 15.24% | -2.44% | 1.6% | 11.15% | 15.86% | 15.86% | 2.04% | 26.64% | 6.45% | 10.93% | 6.75% | 34.39% | 22.14% | 16.38% | 6.2% | 13.78% | 60.82% | 761.36% | -109.36% | 42.86% |
| EBITDA | 1.52B | 1.47B | 1.26B | 1.21B | 1.01B | 1.04B | 790.52M | 640.86M | 574.51M | 496.17M | 428.46M | 368.87M | 319.14M | 321.36M | 314.97M | 284.43M | 249.84M | 225.74M | 221.28M | 177.28M | 157.75M | 139.7M | 126.46M | 99.28M | 85.94M | 78.78M | 72.73M | 64M | 45M | 10M | 57.4M |
| EBITDA Margin % | 34.12% | 34.08% | 32.28% | 33.11% | 30.01% | 32.24% | 29.21% | 26.63% | 25.96% | 25.2% | 24.13% | 23.03% | 21.48% | 23.34% | 24.35% | 23.34% | 22.64% | 21.88% | 21.61% | 19.22% | 21.34% | 21.89% | 23.03% | 20.86% | 20.83% | 20.41% | 19.79% | 17.97% | 14.07% | 3.8% | 21.44% |
| EBITDA Growth % | 18.53% | 16.55% | 3.81% | 19.92% | -2.5% | 31.13% | 23.35% | 11.55% | 15.79% | 15.8% | 16.15% | 15.58% | -0.69% | 2.03% | 10.74% | 13.84% | 10.67% | 2.02% | 24.81% | 12.38% | 12.92% | 10.47% | 27.37% | 15.53% | 9.09% | 8.32% | 13.64% | 42.22% | 350% | -82.58% | 48.7% |
| D&A (Non-Cash Add-back) | 111.12M | 106.46M | 129.94M | 114.91M | 111.9M | 104.6M | 96M | 88.01M | 83.18M | 83.14M | 78.22M | 68.96M | 58.89M | 54.6M | 52.41M | 48.2M | 45.96M | 49.77M | 48.82M | 41.1M | 29.82M | 24.37M | 18.43M | 18.9M | 20.12M | 22.23M | 19.48M | 17.2M | 15.9M | 14.4M | 10.4M |
| EBIT | 1.41B | 1.36B | 1.14B | 1.1B | 899.83M | 932.46M | 695.11M | 553.27M | 492.49M | 418.28M | 353.89M | 302.38M | 261.98M | 268.65M | 264.46M | 237.97M | 204.54M | 176.46M | 174.78M | 136.18M | 127.93M | 115.33M | 108.03M | 80.39M | 65.81M | 56.55M | 53.25M | 46.8M | 29.2M | -4.4M | 47M |
| Net Interest Income | -37.84M | -35.84M | -18.51M | -35.95M | -38.79M | -29.37M | -32.54M | -30.63M | -33.59M | -31.97M | -28.39M | -26.77M | -13.7M | -3.5M | -1.95M | -1.8M | -1.75M | -1.43M | -2.27M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 1.79M | 2.42M | 12.7M | 5.63M | 1.06M | 434K | 586K | 427K | 1.15M | 5.25M | 3.66M | 2.47M | 1.73M | 1.89M | 1.9M | 0 | 0 | 0 | 2.32M | 0 | 0 | 3.14M | 3.07M | 2.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 39.64M | 38.27M | 31.2M | 41.58M | 39.86M | 29.81M | 33.13M | 31.05M | 34.74M | 37.23M | 32.05M | 29.24M | 15.43M | 5.39M | 3.85M | 1.8M | 1.75M | 1.43M | 4.59M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -36.54M | -35.84M | -18.51M | -35.95M | -38.79M | -29.37M | -32.54M | -30.63M | -33.59M | -31.97M | -28.39M | -26.77M | -13.7M | -3.5M | -1.95M | -1.8M | -1.75M | -1.43M | -2.27M | -1.34M | 2.82M | 3.14M | 3.07M | 2.87M | 2.96M | 2.23M | 5M | 5.8M | -30.4M | -27.8M | 8.3M |
| Pretax Income | 1.37B | 1.32B | 1.11B | 1.06B | 859.97M | 902.65M | 661.99M | 522.22M | 457.74M | 381.06M | 321.85M | 273.14M | 246.56M | 263.26M | 260.62M | 234.42M | 202.13M | 174.54M | 170.19M | 134.84M | 130.75M | 118.47M | 111.1M | 83.25M | 68.77M | 58.78M | 58.25M | 52.6M | -1.2M | -32.2M | 55.3M |
| Pretax Margin % | 30.8% | 30.77% | 28.48% | 28.99% | 25.54% | 28.07% | 24.46% | 21.7% | 20.68% | 19.35% | 18.13% | 17.05% | 16.59% | 19.12% | 20.15% | 19.24% | 18.32% | 16.92% | 16.62% | 14.62% | 17.69% | 18.57% | 20.23% | 17.49% | 16.66% | 15.22% | 15.85% | 14.77% | -0.38% | -12.24% | 20.66% |
| Income Tax | 274.31M | 264.73M | 221.96M | 216.13M | 180.88M | 157.81M | 79.85M | 94.43M | 80.69M | 117.79M | 99.79M | 81.01M | 64.6M | 75.47M | 82.33M | 72.67M | 60.81M | 52.3M | 54.02M | 40.83M | 37.22M | 40.67M | 33.16M | 26.28M | 23.38M | 21.16M | 21.61M | 20M | 14M | -11.1M | 22.7M |
| Effective Tax Rate % | 20.03% | 19.99% | 20% | 20.37% | 21.03% | 17.48% | 12.06% | 18.08% | 17.63% | 30.91% | 31.01% | 29.66% | 26.2% | 28.67% | 31.59% | 31% | 30.08% | 29.97% | 31.74% | 30.28% | 28.47% | 34.33% | 29.85% | 31.56% | 34% | 36% | 37.11% | 38.02% | -1166.67% | 34.47% | 41.05% |
| Net Income | 1.1B | 1.06B | 887.87M | 845.04M | 679.09M | 744.85M | 581.78M | 427.72M | 377.03M | 263.14M | 222.04M | 192.08M | 181.91M | 187.8M | 178.27M | 161.79M | 141.28M | 122.22M | 116.17M | 94.01M | 93.68M | 78.25M | 78.33M | 57.09M | 45.39M | 37.62M | 36.63M | 32.6M | -15.2M | -21.1M | 32.6M |
| Net Margin % | 24.63% | 24.62% | 22.78% | 23.08% | 20.17% | 23.17% | 21.49% | 17.77% | 17.04% | 13.36% | 12.51% | 11.99% | 12.24% | 13.64% | 13.78% | 13.28% | 12.8% | 11.85% | 11.34% | 10.19% | 12.67% | 12.26% | 14.26% | 11.99% | 11% | 9.74% | 9.97% | 9.15% | -4.75% | -8.02% | 12.18% |
| Net Income Growth % | 22.38% | 19.33% | 5.07% | 24.44% | -8.83% | 28.03% | 36.02% | 13.44% | 43.28% | 18.51% | 15.6% | 5.59% | -3.14% | 5.35% | 10.19% | 14.51% | 15.59% | 5.21% | 23.57% | 0.36% | 19.71% | -0.1% | 37.21% | 25.78% | 20.65% | 2.7% | 12.37% | 314.47% | 27.96% | -164.72% | 51.63% |
| Net Income (Continuing) | 1.1B | 1.06B | 887.87M | 845.04M | 679.09M | 744.84M | 582.13M | 427.79M | 377.05M | 263.27M | 222.05M | 192.13M | 181.95M | 187.79M | 178.29M | 161.75M | 141.32M | 122.23M | 116.17M | 94.01M | 93.68M | 78.25M | 77.94M | 57.09M | 45.39M | 37.62M | 36.63M | 32.6M | -15.2M | -21.1M | 32.6M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 707K | 352K | 280K | 264K | 139K | 130K | 73K | 28K | 34K | 14K | 46K | 10K | 0 | 0 | 0 | 300K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 13.58 | 13.08 | 10.67 | 10.06 | 8.03 | 8.60 | 6.71 | 4.89 | 4.26 | 2.94 | 2.44 | 2.05 | 1.79 | 1.74 | 1.59 | 1.39 | 1.19 | 1.00 | 0.94 | 0.73 | 0.71 | 0.57 | 0.55 | 0.40 | 0.33 | 0.27 | 0.26 | 0.21 | -0.10 | -0.14 | 0.21 |
| EPS Growth % | 25.32% | 22.59% | 6.06% | 25.28% | -6.63% | 28.17% | 37.22% | 14.79% | 44.9% | 20.49% | 19.02% | 14.53% | 2.87% | 9.43% | 14.39% | 16.81% | 19% | 6.38% | 28.77% | 2.82% | 24.56% | 3.64% | 37.5% | 21.21% | 22.22% | 3.85% | 23.81% | 310% | 28.57% | -166.67% | 40% |
| EPS (Basic) | - | 13.17 | 10.77 | 10.17 | 8.12 | 8.74 | 6.82 | 4.97 | 4.34 | 3.00 | 2.47 | 2.07 | 1.82 | 1.77 | 1.62 | 1.43 | 1.23 | 1.04 | 0.97 | 0.77 | 0.75 | 0.60 | 0.57 | 0.42 | 0.34 | 0.28 | 0.27 | 0.21 | -0.10 | -0.14 | 0.22 |
| Diluted Shares Outstanding | 80.67M | 80.67M | 83.25M | 83.98M | 84.6M | 86.57M | 86.72M | 87.54M | 88.47M | 89.57M | 90.88M | 93.65M | 101.5M | 107.97M | 112.31M | 116.43M | 119.12M | 121.36M | 124.5M | 128.91M | 131.81M | 136.22M | 143.2M | 143.72M | 140.17M | 138.56M | 144.32M | 159.02M | 152M | 150.71M | 157.11M |
| Basic Shares Outstanding | 80.1M | 80.1M | 82.47M | 83.07M | 83.62M | 85.2M | 85.34M | 86.11M | 86.86M | 87.77M | 89.73M | 92.6M | 100.09M | 106.32M | 109.97M | 113.58M | 115.43M | 117.62M | 119.91M | 123.12M | 125.73M | 130.08M | 136.86M | 137.08M | 134.49M | 133.17M | 138.3M | 153.41M | 152M | 150.71M | 148.18M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Veterinary labor supply constraints
As reported in recent financial filings, IDEXX has demonstrated a clear acceleration in top-line performance, with revenue growth climbing from 3.6% in 2025Q1 to 14.3% by 2026Q1, suggesting robust demand for diagnostic consumables and services despite broader macroeconomic headwinds impacting the veterinary sector.
The shift toward double-digit growth indicates that the company's razor-razorblade model is successfully capturing increased diagnostic utilization per visit. Investors should monitor whether this trajectory is sustainable or if it reflects a temporary recovery in clinic foot traffic following previous periods of stagnation.
Based on the provided income statement data, IDEXX has maintained gross margins consistently above 60% over the last ten quarters, peaking at 63.4% in 2026Q1, which highlights the company's significant pricing power and the high intellectual property value inherent in its proprietary diagnostic testing ecosystem.
This margin profile suggests that IDEXX is effectively offsetting inflationary pressures in its laboratory network through premium test adoption. The stability of these margins implies that the company's diagnostic menu remains essential to veterinary workflows, insulating it from the commoditization risks faced by lower-tier diagnostic providers.
According to historical quarterly figures, IDEXX has successfully scaled operating income from $245.3 million in 2023Q4 to $362.6 million in 2026Q1, demonstrating that operating expenses are growing at a slower rate than gross profit, thereby expanding the company's overall operating margin profile.
The ability to expand operating margins while continuing to invest in R&D suggests disciplined overhead management and successful integration of software-driven workflows. This trend warrants further investigation into whether future margin expansion will be driven by continued software-as-a-service penetration or further automation within the reference laboratory network.
Analysis of the income statement reveals that stock-based compensation remains a variable component of the cost structure, with fluctuations such as the $44.1 million credit in 2025Q3, which suggests that reported net income may occasionally be distorted by non-cash accounting adjustments rather than pure operational performance.
While EPS growth has been strong, investors should be cautious of the volatility introduced by these non-operating items when assessing the underlying cash-generating capacity of the business. The absence of consistent SBC charges in recent quarters may indicate a shift in compensation strategy that requires ongoing monitoring.
Quick answers to the most common questions about buying IDXX stock.
For fiscal year 2025, IDEXX Laboratories, Inc. (IDXX) reported total revenue of $4.30B. This represents a 1507.7% increase compared to $267.7M in 1996.
IDEXX Laboratories, Inc. (IDXX) is profitable, generating $1.06B in net income for the fiscal year ending 2025 with a net profit margin of 24.6%.
IDEXX Laboratories, Inc. (IDXX) reported an operating income of $1.36B, resulting in an operating profit margin of 31.6%. This margin reflects the operational efficiency of the business before interest and taxes.
IDEXX Laboratories, Inc. (IDXX) generated $2.66B in gross profit for the year, representing a gross profit margin of 61.8%. This demonstrates the company's core pricing power and production efficiency.